The University of Zurich has granted Humanigen an exclusive license for the prevention of GvHD (Graft-versus-Host Disease) through GM-CSF Neutralization. This deal helps Humanigen expand its extensive intellectual property portfolio to include prevention of...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
